MDisrupt
Connecting healthcare technology companies with health experts.
Connecting healthcare technology companies with health experts.
MDisrupt is a healthtech and life sciences expert marketplace that aims to connect healthtech and life science companies with vetted and curated health experts to assist in the development, commercialization, and scaling of their health products. The company boasts a network of over 2000 experts from renowned institutions such as Blue Cross Blue Shield, CVS, Willis Towers Watson, U.S. FDA, Optum, and Cleveland Clinic.
Established in 2019 and headquartered in the United States, MDisrupt caters to companies across the healthtech and life sciences sectors, including startups, scale-ups, and established enterprise organizations. The company's On Demand Experts span a wide array of expertise, including clinicians, chief medical officers, regulatory experts, lab directors, health economists, and data scientists, among others.
The latest milestone for MDisrupt was the Series A investment on 01 December 2023, with BDev Ventures being the participating investors.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | Unknown | 1 |
|
01 Dec 2023 |
| Seed Round | $3.00M | 9 |
|
20 May 2023 |
| Convertible Note | Unknown | - | 25 Jan 2023 | |
| Seed Round | $6.00M | - | 07 Mar 2022 |
No recent news or press coverage available for MDisrupt.
We care about your data, and we'd love to use cookies make your experience better.
